Concord Drugs

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue12.3710.8010.3913.6110.28
Expenses12.3110.2810.3413.4510.01
EBITDA0.871.391.051.021.10
EBIT0.541.030.670.650.76
Profit Before Tax0.060.530.060.160.27
Net Profit0.040.230.040.120.19
Financial Ratios
Operating Profit Margin7.12%12.87%10.11%7.49%10.70%
Net Profit Margin0.32%2.13%0.38%0.88%1.85%
Earning Per Share (Diluted)0.040.230.040.120.19
Dividends Per Share0.000.000.000.000.00